IL10 and cancer: Tumor-associated macrophages (TAMs), particularly the M2 phenotype, are known to contribute to tumor progression by promoting angiogenesis, enhancing cancer stem cell properties, and inhibiting the activity of cytotoxic T lymphocytes (CTLs) through the secretion of immunosuppressive cytokines such as IL-10 and TGF-β.